Skip to main content
See every side of every news story
Published loading...Updated

‘I was just so depleted I wasn’t able to do it’: A look at postpartum depression

Summary by CTV News
Health Canada has now approved Zuranolone which is sold under the name Zurzuvae. It is the first drug specifically aimed at treating postpartum depression.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

CTV News broke the news in Canada on Thursday, December 11, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal